Articles Referencing LGND

Zacks.com

SPPI Acquires Late-Stage Candidate - Analyst Blog

Spectrum Pharmaceuticals ( SPPI ) recently acquired global development and commercialization rights to Ligand Pharmaceuticals Inc 's ( LGND ) Captisol-enabled, propylene glycol-free... Read >>

David Sterman

Is the Stock Market Overheated? Here's my Plan...

As themarket rises steadily higher, it's getting harder to find true bargains. And though a wide range of good stocks still have reasonably-pricedshares , any market pullback would send most... Read >>

David Sterman

A Low-Risk Pick for my $100,000 Real-Money Portfolio

I've been thinking about biotech stocks a great deal lately. The sector seems to be trading much better in the early weeks of 2012, with a few spectacular gainers already in the bag and... Read >>

David Sterman

3 "Insider" Stocks to Watch this Earnings Season

While many investors moved to the sidelines in August and September, the market slide was no deterrent to officers and directors at many companies. Insider-buying was robust throughout the... Read >>

SeekingAlpha

Three Core Biotech Holdings: Isis, Ligand and Vical

Michael Steinberg submits: Isis ( ISIS ), Ligand ( LGND ) and Vical ( VICL ) have been my core biotech holdings since the mid 1990s and I have been steadily adding to these... Read >>

SeekingAlpha

This Week in Biotech: More Treats than Tricks

The Burrill Report submits: The last week of October was appropriately marked by treats and tricks. The stock market gyrated from investor ebullience over numbers showing a 3.5 percent... Read >>